Stock Chart

TERN

$36.82 +6.42%
Score: 61.7 BUY
LEAPs: SELL $55
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $55
Premium: $10.30
Expiry: Jan 15, 2027
Target: $58
Score: -70

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $25.55 - $36.17 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.81
Vol: 0.71x (vs SPY: 0.7x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About TERN - Terns Pharmaceuticals, Inc. Common Stock

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Key Statistics

Market Cap $4B

This TERN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TERN's price movements with trendlines, gamma walls, and key support/resistance levels.